A detailed history of Newbridge Financial Services Group, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 6,918 shares of ABBV stock, worth $1.34 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
6,918
Previous 6,377 8.48%
Holding current value
$1.34 Million
Previous $988,000 27.43%
% of portfolio
0.56%
Previous 0.49%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

BUY
$159.82 - $182.1 $86,462 - $98,516
541 Added 8.48%
6,918 $1.26 Million
Q4 2023

Mar 28, 2024

SELL
$137.6 - $154.97 $104,300 - $117,467
-758 Reduced 10.62%
6,377 $988,000
Q3 2023

Oct 17, 2023

SELL
$133.59 - $154.65 $47,958 - $55,519
-359 Reduced 4.79%
7,135 $1.06 Million
Q2 2023

Jul 21, 2023

SELL
$132.51 - $164.9 $96,467 - $120,047
-728 Reduced 8.85%
7,494 $1.01 Million
Q1 2023

Apr 18, 2023

BUY
$144.61 - $166.54 $16,340 - $18,819
113 Added 1.39%
8,222 $1.31 Million
Q4 2022

Jan 17, 2023

SELL
$138.31 - $165.87 $276 - $331
-2 Reduced 0.02%
8,109 $0
Q3 2022

Oct 13, 2022

BUY
$134.21 - $153.93 $22,815 - $26,168
170 Added 2.14%
8,111 $1.09 Million
Q2 2022

Jul 15, 2022

BUY
$137.62 - $174.96 $88,076 - $111,974
640 Added 8.77%
7,941 $1.22 Million
Q1 2022

Apr 26, 2022

BUY
$131.98 - $163.75 $220,274 - $273,298
1,669 Added 29.63%
7,301 $1.18 Million
Q4 2021

Jan 19, 2022

BUY
$107.43 - $135.93 $44,153 - $55,867
411 Added 7.87%
5,632 $763,000
Q3 2021

Oct 27, 2021

BUY
$106.4 - $120.78 $41,708 - $47,345
392 Added 8.12%
5,221 $563,000
Q2 2021

Sep 07, 2021

BUY
$105.21 - $117.21 $30,300 - $33,756
288 Added 6.34%
4,829 $544,000
Q1 2021

Sep 07, 2021

BUY
$102.3 - $112.62 $55,958 - $61,603
547 Added 13.7%
4,541 $491,000
Q4 2020

Sep 07, 2021

SELL
$80.49 - $108.67 $32,195 - $43,468
-400 Reduced 9.1%
3,994 $428,000
Q3 2020

Sep 07, 2021

BUY
$85.91 - $100.83 $377,488 - $443,047
4,394 New
4,394 $385,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $342B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Newbridge Financial Services Group, Inc. Portfolio

Follow Newbridge Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.